|
|
||||||||
Ultrasonography |
1 From the Departments of Clinical Pathology (J.H.) and Internal Medicine, Division of Gastroenterology (T.K., K.H., H.K.), Kawasaki Medical School, 577 Matsushima, Kurasiki, Okayama 701-0192, Japan. Received February 18, 2004; revision requested April 23; final revision received October 3; accepted October 12. Address correspondence to J.H. (e-mail: ultrajiro{at}nifty.com).
| ABSTRACT |
|---|
|
|
|---|
MATERIALS AND METHODS: The ethics committee approved this study, and informed consent was obtained from all patients. Fifty-one patients (34 men and 17 women; mean age, 67.1 years) with evidence of small-bowel dilatation at conventional radiography were enrolled. Twenty patients had bowel ischemia (15 cases of bowel strangulation and five of thromboembolism of the superior mesenteric artery) and 31 patients had simple obstruction. After injection of SHU-508A, the most dilated or the least peristaltic bowel segments were imaged at contrast-enhanced power Doppler US (interval, 4 seconds) for 2 minutes. Color signals obtained in the bowel wall were classified as normal, diminished, or absent. Contrast-enhanced US and classification of color signals were performed by a sonologist. The US systems were equipped with 312-MHz transducers. Fisher exact test was used to evaluate the significance of the differences between each group of patients, and P < .01 was considered to indicate a significant difference.
RESULTS: The color signals were absent in five patients with superior mesenteric arterial thromboembolism and in seven patients with strangulation, were diminished in five patients with strangulation, and were normal in three patients with strangulation and in 31 patients with simple obstruction. By pooling the absent and diminished color signals together as a diagnostic indicator of bowel ischemia, the sensitivity was 85% (95% confidence interval [CI]: 62.1%, 96.8%), the specificity was 100% (95% CI: 90.8%, 100%), the positive predictive value was 100% (95% CI: 83.8%, 100%), the negative predictive value was 91.2% (95% CI: 76.3%, 98.1%), the likelihood ratio for a positive test result was infinity, and the likelihood ratio for a negative test result was 0.15 (95% CI: 0.032, 0.379).
CONCLUSION: Contrast-enhanced US shows promise for the noninvasive diagnosis of bowel ischemia based on initial experience in patients with radiographic evidence of small-bowel dilatation.
© RSNA, 2005
| INTRODUCTION |
|---|
|
|
|---|
| MATERIALS AND METHODS |
|---|
|
|
|---|
Among patients with evidence of small-bowel dilatation at conventional radiography who were seen at our hospital between January 2000 and March 2003, 51 patients also underwent US and were enrolled in this study. Decision to perform contrast-enhanced US was made by the attending physician (emergency department), based on the availability of US apparatus, as well as the sonologist and patient's consent. Small-bowel dilatation was defined as a distended bowel loop with air-fluid levels at conventional radiography. A radiologist with expertise in abdominal radiographic examinations interpreted the radiographs.
Twenty patients (14 men and six women; mean age, 65.3 years) had bowel ischemia, while 31 patients (20 men and 11 women; mean age, 68.2 years) had small-bowel dilatation because of obstruction caused by cancer (n = 7) or adhesions as a result of previous surgery (n = 24). There were no significant differences in sex and age distribution between patients with ischemia and patients with obstruction on the basis of the Student t test. Twenty-three patients, including seven patients with colon cancer, were treated successfully with nasointestinal drainage, while eight patients required surgery for the resection of adhesive lesions. The causes of bowel ischemia were bowel strangulation in 15 patients and thromboembolism of the superior mesenteric artery in five patients. Definitive diagnosis was established at the time of surgery (n = 18) and/or autopsy (n = 2) in patients with bowel ischemia. For patients with obstruction, computed tomography (CT) (n = 10), contrast-enhanced (Gastrografin; Nihon Schering, Osaka, Japan) studies (n = 14), or colonoscopy (n = 7), together with clinical course, established the diagnosis. Patients with disseminated intravascular coagulation (n = 1) or severe cardiac failure (n = 1) were excluded from the study since such conditions may alter tissue microcirculation. All of the patients were suitable for the adequate US studies.
US Technique and Interpretation
All patients underwent contrast-enhanced US immediately after patient history and physical findings were obtained by the attending physician (a gastroenterologist). Contrast-enhanced US was performed by a sonologist (J.H.) with 20 years of experience in gastrointestinal US. The sonologist was blinded to the results of other diagnostic tests except for the abdominal radiograph. The time between the appearance of the patient's symptoms and the hospital visit ranged from 1 to 55 hours (mean, 9.8 hours ± 9.2 [standard deviation]).
No special preparations, such as the injection of a spasmolytic or water instillation into the bowel lumen, were performed. First, US of the entire abdomen was performed for 10 minutes to detect any distended small-bowel loops. A distended small-bowel loop was defined as a segment showing more than 2 cm in diameter and a to-and-fro movement of bowel contents. In cases in which intraluminal gas interfered with imaging of the posterior wall of the bowel loop, only the anterior wall was examined. SHU-508A (1500 mg/5 mL, Levovist; Schering, Berlin, Germany) flushed with saline was injected intravenously for 10 seconds. Immediately after injection, the most dilated or the least peristaltic small-bowel segments were scanned with US for 2 minutes. The US systems (SSA-390A and 770A; Toshiba, Tokyo, Japan) were equipped with 312-MHz transducers. The imaging parameters were set as follows: mechanical index of 1.01.2, dynamic range of 50 dB, velocity range of 57.6 cm, and high-pass power Doppler filter cutoff of 130 Hz. The scanning interval was 4 seconds, and monitoring was performed with a low mechanical index to avoid destroying the microbubbles between each scanning. Contrast-enhanced US procedures were recorded on videotape and reviewed immediately after each study by the sonologist blinded to the clinical information to classify the color signals, which required approximately 3 minutes.
The color signals were classified as normal when the signals were similar to those in a normal bowel segment or in the stomach when the entire small bowel was affected, diminished when the signals were weaker than those in a normal bowel segment, or absent when no color signals were observed. Figure 1 shows the color signals. When more than one type of signal was observed, the signal with the poorest enhancement was used. We diagnosed a bowel loop as ischemic when the color signals were diminished or absent.
|
| RESULTS |
|---|
|
|
|---|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Although early diagnosis of bowel ischemia is essential in the management of acute abdominal pain, it has been difficult to establish this diagnosis owing to the lack of typical physical, laboratory, and radiographic findings. Contrast-enhanced CT is one of the methods used for the diagnosis of this disorder (5,6). However, the contrast agents used in CT promptly move into the extravascular space, which results in difficulty differentiating between mild ischemia and congestion. In addition, radiation exposure and the potential renal toxicity of the contrast agents remain a concern. Magnetic resonance imaging has been reported to be another useful method for detecting bowel ischemia (7,8).
There have been many studies about the US assessment of bowel wall blood flow (912). However, most studies are conducted by using color and/or power Doppler US, which has limitations in depicting slow and small amounts of blood flow seen in the mucosal layer of the gastrointestinal wall. In contrast, contrast-enhanced US depicts microperfusion of the gastrointestinal wall as a strong signal produced by the destruction of microbubbles. The scanning method using harmonic imaging was introduced initially in liver studies and was referred to as "flash-echo imaging." With this method, microbubbles reach the target tissues without being destroyed by the ultrasound energy. Recently, US scanning with modalities such as color Doppler, power Doppler, and advanced dynamic flow (wide-band power Doppler imaging) for the visualization of microbubble destruction has become available. The strong color signals obtained with Doppler US are not dependent on blood-flow velocity because the frequency shifts are produced by bubble destruction (loss of correlation) (13). In this study, we advocated the use of the term contrast-enhanced US to include all modalities used for scanning.
There were several limitations in this study. First, the assessment of color signals was subjective. Second, interobserver agreement was not assessed. Contrast-enhanced US requires considerable experience, and thus duplication of our results may vary. Third, the exclusion of patients with disseminated intravascular coagulation and cardiac failure may have biased our results. In addition, our results may not be generalizable to patients with disseminated intravascular coagulation, acute and/or chronic cardiac failure, microcirculatory diseases, or obesity.
Further studies with a greater number of patients are needed to determine the effectiveness of contrast-enhanced US in the differentiation between early strangulation and simple obstruction. Use of a shorter scanning interval (eg, 2 seconds) and generating a time-intensity curve to detect subtle changes in blood-flow dynamics might help differentiate the two entities.
In conclusion, contrast-enhanced US is a promising tool for the assessment of bowel ischemia in patients with radiographic evidence of small-bowel dilatation. By taking the noninvasive nature of the test into account, this method has potential for application in daily practice as a diagnostic method for bowel ischemia.
| FOOTNOTES |
|---|
Abbreviations: CI = confidence interval
Authors stated no financial relationship to disclose.
Author contributions: Guarantor of integrity of entire study, J.H.; study concepts and design, J.H.; literature research, T.K.; clinical studies, J.H.; data acquisition, H.K.; data analysis/interpretation, K.H.; statistical analysis, K.H.; manuscript preparation, definition of intellectual content, and editing, J.H.; manuscript revision/review and final version approval, K.H.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
T Hamada, M Yamauchi, M Tanaka, Y Hashimoto, K Nakai, and K Suenaga Prospective evaluation of contrast-enhanced ultrasonography with advanced dynamic flow for the diagnosis of intestinal ischaemia Br. J. Radiol., August 1, 2007; 80(956): 603 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hamada, K. Kosaka, N. Shigeoka, Y. Hashimoto, M. Yamauchi, S. Cho, K. Nakai, S. Ishimaru, and K. Suenaga Torsion of the Appendix Secondary to Appendiceal Mucocele: Gray Scale and Contrast-Enhanced Sonographic Findings J. Ultrasound Med., January 1, 2007; 26(1): 111 - 115. [Full Text] [PDF] |
||||
![]() |
T. Hamada, M. Tanaka, Y. Hashimoto, M. Yamauchi, N. Shigeoka, K. Nakai, and K. Suenaga Contrast-enhanced sonographic findings of gangrenous meckel diverticulitis. J. Ultrasound Med., September 1, 2006; 25(9): 1227 - 1231. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |